Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
We have a wide range of fun and festive designs to choose from. Fund life changing research while spreading joy this Christmas!
This Christmas, your gift can bring us closer to a cure for type 1 diabetes – and every pound you give to our Christmas Appeal will be doubled.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This event is designed for anyone living with type 1 diabetes who would like to learn more about managing their wellbeing across a variety of contexts.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > About JDRF & our impact > Our research > Information for researchers > Current research funding opportunities > International JDRF funding opportunities
We offer a wide range of funding schemes for researchers in the field of type 1 diabetes and its associated complications, including Strategic Research Agreements, Industry Discovery and Development Partnerships, Innovative Grants and conference grants. We also offer training grants including postdoctoral fellowships, advanced postdoctoral fellowships, career development awards, early-career patient-orientated diabetes research awards and psychology fellowship awards.
The following JDRF funding opportunities are administered by our central office in New York. Read our guidance on applying for JDRF funding for more information about the application process.
The funding aims to support the implementation and integration of evidence based T1D specific behavioural and psychosocial interventions into clinical practice.
This program will award grants up to $1,500,000.00 over 4 years.
Read more about the effectiveness and implementation trials to address mental health in type 1 diabetes.
Funding for single or multiple investigators to address critical gaps and challenges and potential breakthroughs in type 1 diabetes research. The Strategic Research Agreement (SRA) is a partnership between researchers and JDRF scientists to help address roadblocks and accelerate JDRF’s mission through support of cutting-edge scientific investigation.
Read more about the Strategic Research Agreement and how to submit your Project Concept.
The next SRA deadline after this will be 5 November 2024 with a LOI status notification (contact by JDRF staff for further project development) of 13 December 2024.
We accept and review applications for funding opportunities in this section throughout the year.
Our industry partnerships aim to promote for-profit interest in JDRF’s mission to find a cure for type 1 diabetes and its complications, focusing on a priority area within JDRF’s mission. IDDP provides a mechanism and opportunity for JDRF to foster long-term collaborative relationships with industry, taking promising type 1 diabetes research through discovery and development and toward commercialisation.
This funding opportunity is aimed at biotechnology and pharmaceutical companies or other public or private for-profit organisations. We encourage applications from companies proposing collaboration with academic researchers.
For more information about this opportunity, including current and past partnerships, please visit our Industry Research Partnerships page.
We offer financial support for scientific meetings, conferences, and workshops relevant to JDRF’s mission of eradicating type 1 diabetes and its effects on people. Funding is provided for organisation and delivery of an event and does not provide individual support to an applicant for conference attendance.
You should submit your conference grant application three to six months prior to your proposed meeting date. Read more about our conference grants including eligibility criteria and how to apply.
These funding opportunities below have now closed but give you an idea of the type of research topics JDRF funds. You can also find details of key dates for when you will hear whether your application has been approved and when we expect the funded projects to start.
The funding aims to support the advancement of early preclinical stage hypoimmunogenic pluripotent stem cells (PSCs) for beta cell replacement in type 1 diabetes into late preclinical or pilot clinical testing.
The primary objective is to further develop established genetically modified beta/islet cells derived from PSCs with immune evasive properties through late preclinical validation, scaling, and clinical testing which will ultimately lead to type 1 diabetes therapies.
Read more about the Translation of hypoimmunogenic beta/islet cell sources into late preclinical/clinical testing for cell therapies in T1D.
This funding call is titled Accelerating Collaborative Research in Type 1 Diabetes Etiology and Pathogenesis using Biosamples from an Observational Clinical Study. It is open to researchers anywhere in the world.
The funding aims to support collaborations with ENDIA investigators to improve understanding of the etiology and pathogenesis of type 1 diabetes during gestation and early childhood.
This call seeks new collaborators outside of the current network of ENDIA investigators to carry out research using data and biosamples from ENDIA. Relevant proposals led by investigators whose expertise is not type 1 diabetes are also encouraged.
ENDIA will provide biosamples, relevant clinical metadata and additional support. JDRF Australia and Helmsley will provide funding to cover project activities.
Funding for single or multiple investigators to address critical gaps and challenges and potential breakthroughs in type 1 diabetes research. The Strategic Research Agreement is a partnership between researchers and JDRF scientists to help address roadblocks and accelerate JDRF’s mission through support of cutting-edge scientific investigation.
Our Small Grant Awards offer funding of up to £25,000 for a maximum of 12 months, for UK-based early career researchers.
Discover the opportunities for research projects funded in partnership with other organisations.
Learn more about how JDRF can help you to involve people with lived experience in your research.
